Shah, Karan B.Shah, Bhavesh S.Malhotra, Supriya D.Patel, Pankaj R.2020-04-232020-04-232019-01Shah Karan B., Shah Bhavesh S., Malhotra Supriya D., Patel Pankaj R.. Oseltamivir induced sinus bradycardia: an area of potential concern. International Journal of Basic & Clinical Pharmacology. 2019 Jan; 8(1): 162-1652319-20032279-0780http://imsear.searo.who.int/handle/123456789/199993Oseltamivir was approved for the prevention and treatment of influenza in 1999 by the USFDA (US Food and Drug Administration). The use of Oseltamivir is increasing rapidly all over the world, especially after the 2009 “Swine Flu” pandemic. Less data is published as far as the cardiovascular side effects of Oseltamivir are concerned, but it could be associated with some serious cardiovascular side effects. This study presented a case series of 5 cases suspected to be suffering from seasonal influenza H1N1 (“Swine Flu”), who developed sinus bradycardia while they were on Oseltamivir therapy.BradycardiaH1N1OseltamivirSwine fluJournal ArticleIndiaDepartment of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, IndiaDirector, Pooja Hospital, Opp. New bus stand, Kapadwanj, Gujarat 387620, IndiaHead, Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, IndiaDean, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India